Prevalencia del síndrome metabólico en pacientes con psoriasis entre 20 - 45 años en el Hospital General del Norte de Guayaquil IESS Los Ceibos durante el periodo enero de 2021 – junio 2022.

Abstract

Psoriasis affects 2% of the world's population and is one of the most common chronic inflammatory diseases. According to descriptive studies, the prevalence of metabolic syndrome in patients with psoriasis varies throughout Latin America, from 40% in Mexico, 46% in Peru to 70% in Honduras. Similar immunological mechanisms underlie the relationship between psoriasis and metabolic syndrome; specifically, abdominal fat acts by secreting cytokines (adipokines) that promote inflammation, modifying glucose metabolism and vascular endothelium. Objective: To determine the prevalence of Metabolic Syndrome in patients with Psoriasis between 20 - 45 years old in the Hospital General del Norte de Guayaquil IESS Los Ceibos durin g the period January 2021 - June 2022. Methods and Materials: This is an observational, retrospective, cross-sectional and descriptive study. The data collection technique was based on the documentation of variables obtained from digital medical records registered in the Integrated Health Information System AS-400, with a total population of 250 patients. Results: In the present study it was found that the prevalence of Metabolic Syndrome in patients with Psoriasis between 20 - 45 years old was 45.60%. Conclusion: The prevalence of Metabolic Syndrome in patients with Psoriasis between 20 - 45 years is high, but there is no evidence to support a relationship between metabolic syndrome and Psoriasis severity with laboratory and anthropometric data obtained, the pathology does not seem to be affected, so it remains a rare disease in our environment.